Return On Equity of ADIAL PHARMACEUTICALS, INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ADIAL PHARMACEUTICALS, INC. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • ADIAL PHARMACEUTICALS, INC. Return On Equity for the quarter ending 30 Sep 2025 was -198%, a 23% increase year-over-year.
  • ADIAL PHARMACEUTICALS, INC. annual Return On Equity for 2024 was -259%, a 42% decline from 2023.
  • ADIAL PHARMACEUTICALS, INC. annual Return On Equity for 2023 was -183%, a 1.5% increase from 2022.
  • ADIAL PHARMACEUTICALS, INC. annual Return On Equity for 2022 was -186%, a 49% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ADIAL PHARMACEUTICALS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -198% +59% +23% 01 Jul 2025 30 Sep 2025
Q2 2025 -191% +100% +34% 01 Apr 2025 30 Jun 2025
Q1 2025 -219% +0.37% +0.17% 01 Jan 2025 31 Mar 2025
Q4 2024 -259% -76% -42% 01 Oct 2024 31 Dec 2024
Q3 2024 -256% -22% -9.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -291% -59% -26% 01 Apr 2024 30 Jun 2024
Q1 2024 -219% +62% +22% 01 Jan 2024 31 Mar 2024
Q4 2023 -183% +2.9% +1.5% 01 Oct 2023 31 Dec 2023
Q3 2023 -234% -6.5% -2.8% 01 Jul 2023 30 Sep 2023
Q2 2023 -232% -1.8% -0.76% 01 Apr 2023 30 Jun 2023
Q1 2023 -282% -15% -5.6% 01 Jan 2023 31 Mar 2023
Q4 2022 -186% +181% +49% 01 Oct 2022 31 Dec 2022
Q3 2022 -228% +88% +28% 01 Jul 2022 30 Sep 2022
Q2 2022 -230% +69% +23% 01 Apr 2022 30 Jun 2022
Q1 2022 -267% -56% -26% 01 Jan 2022 31 Mar 2022
Q4 2021 -367% -196% -114% 01 Oct 2021 31 Dec 2021
Q3 2021 -315% -183% -138% 01 Jul 2021 30 Sep 2021
Q2 2021 -299% -195% -187% 01 Apr 2021 30 Jun 2021
Q1 2021 -211% -107% -103% 01 Jan 2021 31 Mar 2021
Q4 2020 -171% -80% -88% 01 Oct 2020 31 Dec 2020
Q3 2020 -133% -44% -49% 01 Jul 2020 30 Sep 2020
Q2 2020 -104% +79% +43% 01 Apr 2020 30 Jun 2020
Q1 2020 -104% +177% +63% 01 Jan 2020 31 Mar 2020
Q4 2019 -91% +596% +87% 01 Oct 2019 31 Dec 2019
Q3 2019 -89% 01 Jul 2019 30 Sep 2019
Q2 2019 -183% 01 Apr 2019 30 Jun 2019
Q1 2019 -281% 01 Jan 2019 31 Mar 2019
Q4 2018 -687% 01 Oct 2018 31 Dec 2018

ADIAL PHARMACEUTICALS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -259% -76% -42% 01 Jan 2024 31 Dec 2024
2023 -183% +2.9% +1.5% 01 Jan 2023 31 Dec 2023
2022 -186% +181% +49% 01 Jan 2022 31 Dec 2022
2021 -367% -196% -114% 01 Jan 2021 31 Dec 2021
2020 -171% -80% -88% 01 Jan 2020 31 Dec 2020
2019 -91% +596% +87% 01 Jan 2019 31 Dec 2019
2018 -687% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.